EN

DE


 

 

 

 

Legal Situation

Legal Situation in Switzerland

 

In Switzerland, Cannabis with a THC content of up to 1% is legal since 2016, whereas in the EU the THC content limit is set to 0.2%. The main cannabinoid content in these low THC Cannabis varieties is cannabidiol, or CBD for short.

 

CBD has corresponding medical effects without showing the psychoactive effects of tetrahydrocannabinol, or THC for short.

 

 

Cannabis strains with higher THC content contain also a higher percentage of CBD and they overall yield more harvest (up to 40%). The Swiss limit has therefore made Switzerland into a very competitive player for Cannabis production in Europe. Producers are using Cannabis strains with up to 1% THC content to grow CBD flower, and then wash out the excess THC to get below 0.2% for the export into European markets.

 

Recent developments and legislative rulings in Switzerland have paved the way to further liberalize the recreational consumption of THC products (Cannabis containing > 1% THC). From 2022 onward also the production and trade of THC will be further liberalized, with the rulings specifically targeting the medical market.

 

 

Limits in different jurisdictions

 

 

THC content

CBD

Switzerland

< 1%

unrestricted

Germany

< 0.2%

unrestricted

Austria

< 0.3%

legal gray area

EU in general

< 0.2%

it's complicated

USA (federal law)

< 0.3%

legal gray area

Canada

legal with restrictions since 2018

unrestricted

 

Source: https://www.visualcapitalist.com/european-cbd-landscape-in-2020/

 

 

 

Legal Situation Globally

 

The global situation in the area of recreational use of cannabis is as follows:

 

 

 

 

In the field of medical cannabis, the situation is as follows:

 

 

 

Source: https://de.wikipedia.org/wiki/Rechtslage_von_Cannabis

 

 

 

Recent Legislative Developments (2021)

 

A number of jurisdictions and entities have recently taken steps to further decriminalize the recreational use of cannabis and also to pave the way for the use of cannabis in the medical field. The most notable ones are:

 

Switzerland: Green light for cannabis trials: the federal government is already having hemp varieties tested

https://www.tagesanzeiger.ch/gruenes-licht-fuer-cannabis-versuche-bund-laesst-bereits-hanfsorten-testen-460211411430

 

Germany: Medical cannabis re-classified as basic recipe material

https://m.apotheke-adhoc.de/nachrichten/detail/politik/olg-cannabis-ist-kein-arzneimittel/

 

EU / EuGH verdict: CBD not a narcotic, but foodstuff / novel food

https://www.apotheke-adhoc.de/nachrichten/detail/politik/eu-rudert-zurueck-cbd-kann-als-nahrungsmittel-betrachtet-werden/

 

UN reclassifies Cannabis as non narcotics

https://www.nytimes.com/2020/12/02/world/europe/cannabis-united-nations-drug-policy.html

 

USA: US House of Representatives passes bill to decriminalize Cannabis at federal level

https://www.bbc.com/news/world-us-canada-55191808

 

USA: More and more states in the US are legalizing cannabis

https://www.myweedo.de/gruene-seiten/politik/legalisierungsjahr-2021-usa-cannabis-boom

 

 

 

 
 

© Swiss Cannabis Association